Cannabinoids as potential new therapy for the treatment of gliomas

  title={Cannabinoids as potential new therapy for the treatment of gliomas},
  author={D. Parolaro and P. Massi},
  journal={Expert Review of Neurotherapeutics},
  pages={37 - 49}
  • D. Parolaro, P. Massi
  • Published 2008
  • Medicine
  • Expert Review of Neurotherapeutics
  • Gliomas constitute the most frequent and malignant primary brain tumors. Current standard therapeutic strategies (surgery, radiotherapy and chemotherapeutics, e.g., temozolomide, carmustin or carboplatin) for their treatment are only palliative and survival diagnosis is normally 6–12 months. The development of new therapeutic strategies for the management of gliomas is therefore essential. Interestingly, cannabinoids have been shown to exert antiproliferative effects on a wide spectrum of cells… CONTINUE READING
    29 Citations
    Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233
    • 20
    Cannabinoids as seed compounds for the cancer treatment
    • 1
    Update on the endocannabinoid system as an anticancer target
    • 56
    • PDF
    Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
    • 41
    • PDF
    WIN55,212-2 induces caspase-independent apoptosis on human glioblastoma cells by regulating HSP70, p53 and Cathepsin D.
    • 7
    Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
    • 93
    • PDF
    Cannabidiol: State of the art and new challenges for therapeutic applications.
    • 175
    • PDF


    Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.
    • 356
    • PDF
    Cannabinoids Induce Glioma Stem-like Cell Differentiation and Inhibit Gliomagenesis*
    • 109
    • PDF
    Arachidonylethanolamide Induces Apoptosis of Human Glioma Cells through Vanilloid Receptor‐1
    • 59
    • PDF
    Novel immunotherapeutic approaches to glioma.
    • R. Yamanaka
    • Medicine
    • Current opinion in molecular therapeutics
    • 2006
    • 17
    Temozolomide: realizing the promise and potential
    • 42